Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 517

Results For "AP"

8349 News Found

Eni and Dompe farmaceutici join forces for health research
News | October 11, 2023

Eni and Dompe farmaceutici join forces for health research

Eni will guarantee Dompé researchers access to its laboratories, support from the company's specialized staff, and use of its HPC5 supercomputer


AstraZeneca’s Tagrisso to lead lung cancer small molecule market with over $7 billion sales by 2029, says GlobalData
News | October 11, 2023

AstraZeneca’s Tagrisso to lead lung cancer small molecule market with over $7 billion sales by 2029, says GlobalData

Tagrisso is projected to be a pivotal contributor to AstraZeneca’s portfolio


Philips and World Stroke Organization partner to improve access to high-quality stroke care
News | October 11, 2023

Philips and World Stroke Organization partner to improve access to high-quality stroke care

Two-year partnership focused on advocacy, education, and raising awareness of stroke as a global healthcare challenge


Evonik introduces the world’s first carbon-fiber reinforced PEEK filament for 3D printed medical implants
News | October 11, 2023

Evonik introduces the world’s first carbon-fiber reinforced PEEK filament for 3D printed medical implants

Alignment of carbon-fiber can be controlled during the 3D printing process


Veramed acquires Clinical Trial Data Services
News | October 09, 2023

Veramed acquires Clinical Trial Data Services

Clinical Trial Data Services supports small to midsize sponsor companies helping them to take the next step towards market approval for their drug or device product.


Thermo Fisher Scientific expands St. Louis manufacturing for complex biologic treatments
News | October 09, 2023

Thermo Fisher Scientific expands St. Louis manufacturing for complex biologic treatments

Increased capability to produce medicines for challenging diseases including cancer


Biocon Biologics gets complete response letter from USFDA for Biosimilar Insulin Aspart
Drug Approval | October 09, 2023

Biocon Biologics gets complete response letter from USFDA for Biosimilar Insulin Aspart

The company had submitted a comprehensive Corrective and Preventive Action (CAPA) plan in September 2022


Biocon signs commercialization agreement with Juno Pharmaceuticals in Canada
News | October 09, 2023

Biocon signs commercialization agreement with Juno Pharmaceuticals in Canada

Biocon will be responsible for obtaining regulatory approval for Liraglutide, and thereafter, for the manufacture and supply of the product in the Canadian market


American Oncology Institute launched Bone Marrow Transplant programs in India
Healthcare | October 09, 2023

American Oncology Institute launched Bone Marrow Transplant programs in India

Expanding to states like Maharashtra, Andhra Pradesh, Telangana, and Manipur while marking the significant milestone in its journey towards providing accessible healthcare services